Every day, CereMetrix™ plays a pivotal role in brain diagnostics by improving radiological insight and streamlining clinical practice. One of the things that sets it apart is its use of a population template, a large dataset of clinical scans, to help radiologists identify atypical perfusion patterns. This FDA-approved quantification method helps radiologists and patients be confident in their results. Don’t just take it from us, see what one of our top clinical providers has to say:
“The level of accuracy encompassed in CereMetrix’s population template provides a clear pathway to identify abnormalities, which in turn allows me to explain the connection to my patient’s symptoms,” said Shaun O’Leary, MD, PhD, a Chicago neurosurgeon who has been using CereMetrix’s reporting since 2018. “I can tell my patients that abnormalities identified in their quantitative brain imaging have been vetted through a method that is as good as the present gold standard AND will continue to get better as more patients are included.“
To learn more about how we validated the population template, check out our press release (link) and Lindsay Quandt’s virtual presentation at SNMMI 2020 July 11-14 (link).
To see how you can be on the forefront of innovation in your radiologic or clinical practice, schedule a CereMetrix™ demo today through Request a Demo.